Intratubular germ cell neoplasms of the testis and bilateral testicular tumors: Clinical significance and management options

Indian Journal of Urology

Volumn 26, Issue 1, 2010, Pages 64-71

  Risk, Michael C ^a   Masterson, Timothy A ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Bilateral testicular cancer; Intratubular germ cell neoplasia; Testicular germ cell tumor

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P18;

BILATERAL TESTICULAR CANCER; BLOOD VESSEL INJURY; CANCER GROWTH; CANCER INCIDENCE; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CONFERENCE PAPER; CRYPTORCHISM; EDEMA; GERM CELL TUMOR; HEMATOMA; HUMAN; INFERTILITY; MALE; ORCHIECTOMY; PATHOGENESIS; PREVALENCE; PROTEIN EXPRESSION; RADIATION DOSE; STONE FORMATION; TESTIS BIOPSY; TESTIS TUMOR; TREATMENT OUTCOME;

EID: 77950574389     PISSN: 09701591     EISSN: 19983824     Source Type: Journal    
DOI: 10.4103/0970-1591.60454     Document Type: Conference Paper

References (114)

1. Horner MJ, Ries LA, Krapcho M, Neyman N, Aminou R, Howlader N, et al. editors. SEER cancer statistics review, 1975-2006. Bethesda, MD: National Cancer Institute; 2009
2. Baade P, Carriere P, Fritschi L. Trends in testicular germ cell cancer incidence in Australia. Cancer Causes Control 2008;19:1043-1049
3. Matsuda T, Saika K. Comparison of time trends in testicular cancer incidence (1973-1997) in East Asia, Europe and USA, from Cancer Incidence in Five Continents Vols IV-VIII. Jpn J Clin Oncol 2008;38:578-579
4. Skakkebaek NE. Possible carcinoma-in-situ of the testis. Lancet 1972;2:516-517
5. von der Maase H, Rorth M, Walbom-Jorgensen S, Sorensen BL, Christophersen IS, Hald T, et al. Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients. Br Med J (Clin Res Ed) 1986;293:1398-1401
6. Bray F, Ferlay J, Devesa SS, McGlynn KA, Moller H. Interpreting the international trends in testicular seminoma and nonseminoma incidence. Nat Clin Pract Urol 2006;3:532-543
7. Lacerda HM, Akre O, Merletti F, Richiardi L. Time trends in the incidence of testicular cancer in childhood and young adulthood. Cancer Epidemiol Biomarkers Prev 2009;18:2042-2045
8. Skakkebaek NE. Atypical germ cells in the adjacent "normal" tissue of testicular tumours. Acta Pathol Microbiol Scand A 1975;83:127-130
9. Jacobsen GK, Henriksen OB, von der Maase H. Carcinoma in situ of testicular tissue adjacent to malignant germ-cell tumors: a study of 105 cases. Cancer 1981;47:2660-2662
10. Coffin CM, Ewing S, Dehner LP. Frequency of intratubular germ cell neoplasia with invasive testicular germ cell tumors. Histologic and immunocytochemical features. Arch Pathol Lab Med 1985;109:555-559
11. Klein FA, Melamed MR, Whitmore WF Jr. Intratubular malignant germ cells (carcinoma in situ) accompanying invasive testicular germ cell tumors. J Urol 1985;133:413-415
12. Giwercman A, Muller J, Skakkebaek NE. Prevalence of carcinoma in situ and other histopathological abnormalities in testes from 399 men who died suddenly and unexpectedly. J Urol 1991;145:77-80
13. Linke J, Loy V, Dieckmann KP. Prevalence of testicular intraepithelial neoplasia in healthy males. J Urol 2005;173:1577-1579
14. Pryor JP, Cameron KM, Chilton CP, Ford TF, Parkinson MC, Sinokrot J, et al. Carcinoma in situ in testicular biopsies from men presenting with infertility. Br J Urol 1983;55:780-784
15. Skakkebaek NE. Carcinoma in situ of the testis: frequency and relationship to invasive germ cell tumours in infertile men. Histopathology 1978;2:157-170
16. Bettocchi C, Coker CB, Deacon J, Parkinson C, Pryor JP. A review of testicular intratubular germ cell neoplasia in infertile men. J Androl 1994;15:14S-6S
17. Jacobsen GK, Norgaard-Pedersen B. Placental alkaline phosphatase in testicular germ cell tumours and in carcinoma-in-situ of the testis. An immunohistochemical study. Acta Pathol Microbiol Immunol Scand A 1984;92:323-329
18. Manivel JC, Jessurun J, Wick MR, Dehner LP. Placental alkaline phosphatase immunoreactivity in testicular germ-cell neoplasms. Am J Surg Pathol 1987;11:21-29
19. Giwercman A, Marks A, Bailey D, Baumal R, Skakkebaek NE. A monoclonal antibody as a marker for carcinoma in situ germ cells of the human adult testis. Apmis 1988;96:667-670
20. Giwercman A, Lindenberg S, Kimber SJ, Andersson T, Muller J, Skakkebaek NE. Monoclonal antibody 43-9F as a sensitive immunohistochemical marker of carcinoma in situ of human testis. Cancer 1990;65:1135-1142
21. Giwercman A, Andrews PW, Jorgensen N, Muller J, Graem N, Skakkebaek NE. Immunohistochemical expression of embryonal marker TRA-1- 60 in carcinoma in situ and germ cell tumors of the testis. Cancer 1993;72:1308-1314
22. Hoei-Hansen CE, Almstrup K, Nielsen JE, Brask Sonne S, Graem N, Skakkebaek NE, et al. Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours. Histopathology 2005;47:48-56
23. Hart AH, Hartley L, Parker K, Ibrahim M, Looijenga LH, Pauchnik M, et al. The pluripotency homeobox gene NANOG is expressed in human germ cell tumors. Cancer 2005;104:2092-2098
24. Hoei-Hansen CE, Nielsen JE, Almstrup K, Sonne SB, Graem N, Skakkebaek NE, et al. Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors. Clin Cancer Res 2004;10:8521-8530
25. Rajpert-De Meyts E, Skakkebaek NE. Expression of the c-kit protein product in carcinoma-in-situ and invasive testicular germ cell tumours. Int J Androl 1994;17:85-92
26. de Jong J, Stoop H, Dohle GR, Bangma CH, Kliffen M, Van Esser JW, et al. Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumours. J Pathol 2005;206:242-249
27. Hawkins E, Heifetz SA, Giller R, Cushing B. The prepubertal testis (prenatal and postnatal): its relationship to intratubular germ cell neoplasia: a combined Pediatric Oncology Group and Children's Cancer Study Group. Hum Pathol 1997;28:404-410
28. Summersgill B, Osin P, Lu YJ, Huddart R, Shipley J. Chromosomal imbalances associated with carcinoma in situ and associated testicular germ cell tumours of adolescents and adults. Br J Cancer 2001;85:213-220
29. van Echten J, van Gurp RJ, Stoepker M, Looijenga LH, De Jong J, Oosterhuis W. Cytogenetic evidence that carcinoma in situ is the precursor lesion for invasive testicular germ cell tumors. Cancer Genet Cytogenet 1995;85:133-137
30. Gillis AJ, Looijenga LH, De Jong B, Oosterhuis JW. Clonality of combined testicular germ cell tumors of adults. Lab Invest 1994;71:874-878
31. Bartkova J, Thullberg M, Rajpert-De Meyts E, Skakkebaek NE, Bartek J. Cell cycle regulators in testicular cancer: loss of p18INK4C marks progression from carcinoma in situ to invasive germ cell tumours. Int J Cancer 2000;85:370-375
32. Di Vizio D, Cito L, Boccia A, Chieffi P, Insabato L, Pettinato G, et al. Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors. Oncogene 2005;24:1882-1894
33. Looijenga LH, Zafarana G, Grygalewicz B, Summersgill B, Debiec-Rychter M, Veltman J, et al. Role of gain of 12p in germ cell tumour development. Apmis 2003;111:161-171
34. Gondos B, Berthelsen JG, Skakkebaek NE. Intratubular germ cell neoplasia (carcinoma in situ): a preinvasive lesion of the testis. Ann Clin Lab Sci 1983;13:185-192
35. Jorgensen N, Rajpert-De Meyts E, Graem N, Muller J, Giwercman A, Skakkebaek NE. Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells. Lab Invest 1995;72:223-231
36. Honecker F, Stoop H, De Krijger RR, Chris Lau YF, Bokemeyer C, Looijenga LH. Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells. J Pathol 2004;203:849-857
37. Jorgensen N, Giwercman A, Muller J, Skakkebaek NE. Immunohistochemical markers of carcinoma in situ of the testis also expressed in normal infantile germ cells. Histopathology 1993;22:373-378
38. Hoei-Hansen CE, Nielsen JE, Almstrup K, Hansen MA, Skakkebaek NE, Rajpert-DeMeyts E, et al. Identification of genes differentially expressed in testes containing carcinoma in situ. Mol Hum Reprod 2004;10:423-431
39. Sonne SB, Almstrup K, Dalgaard M, Juncker AS, Edsgard D, Ruban L, et al. Analysis of gene expression profiles of microdissected cell populations indicates that testicular carcinoma in situ is an arrested gonocyte. Cancer Res 2009;69:5241-5250
40. Eckert D, Biermann K, Nettersheim D, Gillis AJ, Steger K, Jack HM, et al. Expression of BLIMP1/PRMT5 and concurrent histone H2A/H4 arginine 3 dimethylation in fetal germ cells, CIS/IGCNU and germ cell tumors. BMC Dev Biol 2008;8:106
41. Netto GJ, Nakai Y, Nakayama M, Jadallah S, Toubaji A, Nonomura N, et al. Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors. Mod Pathol 2008;21:1337-1344
42. Moller H. Decreased testicular cancer risk in men born in wartime. J Natl Cancer Inst 1989;81:1668-1669
43. Myrup C, Wohlfahrt J, Oudin A, Schnack T, Melbye M. Risk of testicular cancer according to birthplace and birth cohort in Denmark. Int J Cancer 2009;126:217-223
44. Hemminki K, Li X. Cancer risks in second-generation immigrants to Sweden. Int J Cancer 2002;99:229-237 (Pubitemid 34309480)
45. Hemminki K, Li X, Czene K. Cancer risks in first-generation immigrants to Sweden. Int J Cancer 2002;99:218-228 (Pubitemid 34309479)
46. Hemminki K, Li X. Familial risk in testicular cancer as a clue to a heritable and environmental aetiology. Br J Cancer 2004;90:1765-1770
47. Sonne SB, Kristensen DM, Novotny GW, Olesen IA, Nielsen JE, Skakkebaek NE, et al. Testicular dysgenesis syndrome and the origin of carcinoma in situ testis. Int J Androl 2008;31:275-287
48. Shah MN, Devesa SS, Zhu K, McGlynn KA. Trends in testicular germ cell tumours by ethnic group in the United States. Int J Androl 2007;30:206-213
49. Dieckmann KP, Pichlmeier U. Clinical epidemiology of testicular germ cell tumors. World J Urol 2004;22:2-14
50. Berthelsen JG, Skakkebaek NE, von der Maase H, Sorensen BL, Mogensen P. Screening for carcinoma in situ of the contralateral testis in patients with germinal testicular cancer. Br Med J (Clin Res Ed) 1982;285:1683-1686
51. Dieckmann KP, Loy V. Prevalence of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell neoplasms. J Clin Oncol 1996;14:3126-3132
52. Harland SJ, Cook PA, Fossa SD, Horwich A, Mead GM, Parkinson MC, et al. Intratubular germ cell neoplasia of the contralateral testis in testicular cancer: defining a high risk group. J Urol 1998;160:1353-1357
53. Harland SJ, Cook PA, Fossa SD, Horwich A, Parkinson MC, Roberts JT, et al. Risk factors for carcinoma in situ of the contralateral testis in patients with testicular cancer. An interim report. Eur Urol 1993;23:115-118
54. Lenz S, Skakkebaek NE, Hertel NT. Abnormal ultrasonic pattern in contralateral testes in patients with unilateral testicular cancer. World J Urol 1996;14:S55-8
55. Walsh TJ, Croughan MS, Schembri M, Chan JM, Turek PJ. Increased risk of testicular germ cell cancer among infertile men. Arch Intern Med 2009;169:351-356
56. Olesen IA, Hoei-Hansen CE, Skakkebaek NE, Petersen JH, Rajpert-De Meyts E, Jorgensen N. Testicular carcinoma in situ in subfertile Danish men. Int J Androl 2007;30:406-411 (Pubitemid 47254434)
57. Akre O, Pettersson A, Richiardi L. Risk of contralateral testicular cancer among men with unilaterally undescended testis: a meta analysis. Int J Cancer 2009;124:687-689
58. Wood HM, Elder JS. Cryptorchidism and testicular cancer: separating fact from fiction. J Urol 2009;181:452-461
59. Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O. Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med 2007;356:1835-1841
60. Walsh TJ, Dall'Era MA, Croughan MS, Carroll PR, Turek PJ. Prepubertal orchiopexy for cryptorchidism may be associated with lower risk of testicular cancer. J Urol 2007;178:1440-1446
61. Krabbe S, Skakkebaek NE, Berthelsen JG, Eyben FV, Volsted P, Mauritzen K, et al. High incidence of undetected neoplasia in maldescended testes. Lancet 1979;1:999-1000
62. Giwercman A, Bruun E, Frimodt-Moller C, Skakkebaek NE. Prevalence of carcinoma in situ and other histopathological abnormalities in testes of men with a history of cryptorchidism. J Urol 1989;142:998-1001
63. Skakkebaek NE. Carcinoma-in-situ of testis in testicular feminization syndrome. Acta Pathol Microbiol Scand A 1979;87:87-89
64. Muller J, Skakkebaek NE, Ritzen M, Ploen L, Petersen KE. Carcinoma in situ of the testis in children with 45,X/46,XY gonadal dysgenesis. J Pediatr 1985;106:431-436
65. Cassio A, Cacciari E, D'Errico A, Balsamo A, Grigioni FW, Pascucci MG, et al. Incidence of intratubular germ cell neoplasia in androgen insensitivity syndrome. Acta Endocrinol (Copenh) 1990;123:416-422
66. Slowikowska-Hilczer J, Szarras-Czapnik M, Kula K. Testicular pathology in 46,XY dysgenetic male pseudohermaphroditism: an approach to pathogenesis of testis cancer. J Androl 2001;22:781-792
67. von Eckardstein S, Tsakmakidis G, Kamischke A, Rolf C, Nieschlag E. Sonographic testicular microlithiasis as an indicator of premalignant conditions in normal and infertile men. J Androl 2001;22:818-824
68. DeCastro BJ, Peterson AC, Costabile RA. A 5-year followup study of asymptomatic men with testicular microlithiasis. J Urol 2008;179:1420-1423
69. Sanli O, Kadioglu A, Atar M, Acar O, Nane I. Grading of classical testicular microlithiasis has no effect on the prevalence of associated testicular tumors. Urol Int 2008;80:310-316
70. Holm M, Hoei-Hansen CE, Rajpert-De Meyts E, Skakkebaek NE. Increased risk of carcinoma in situ in patients with testicular germ cell cancer with ultrasonic microlithiasis in the contralateral testicle. J Urol 2003;170:1163-1167
71. de Gouveia Brazao CA, Pierik FH, Oosterhuis JW, Dohle GR, Looijenga LH, Weber RF. Bilateral testicular microlithiasis predicts the presence of the precursor of testicular germ cell tumors in subfertile men. J Urol 2004;171:158-160
72. Elzinga-Tinke JE, Sirre ME, Looijenga LH, Van Casteren N, Wildhagen MF, Dohle GR. The predictive value of testicular ultrasound abnormalities for carcinoma in situ of the testis in men at risk for testicular cancer. Int J Androl 2009 Oct 21. [In press]
73. Gondos B, Migliozzi JA. Intratubular germ cell neoplasia. Semin Diagn Pathol 1987;4:292-303
74. van Casteren NJ, Boellaard WP, Dohle GR, Weber RF, Kuizinga MC, Stoop H, et al. Heterogeneous distribution of ITGCNU in an adult testis: consequences for biopsy-based diagnosis. Int J Surg Pathol 2008;16:21-24
75. Prym C, Lauke H. Carcinoma-in situ of the human testis: tumour cells are distributed focally in the seminiferous tubules. Andrologia 1994;26:231-234
76. van Casteren NJ, de Jong J, Stoop H, Steyerberg EW, de Bekker-Grob EW, Dohle GR, et al. Evaluation of testicular biopsies for carcinoma in situ: immunohistochemistry is mandatory. Int J Androl 2008 Sep 16. [In press]
77. Ulbright TM. Germ cell neoplasms of the testis. Am J Surg Pathol 1993;17:1075-1091
78. Jones TD, Ulbright TM, Eble JN, Cheng L. OCT4: A sensitive and specific biomarker for intratubular germ cell neoplasia of the testis. Clin Cancer Res 2004;10:8544-8547
79. Hoei-Hansen CE, Rajpert-De Meyts E, Carlsen E, Almstrup K, Leffers H, Skakkebaek NE. A subfertile patient diagnosed with testicular carcinoma in situ by immunocytological staining for AP-2gamma in semen samples: case report. Hum Reprod 2005;20:579-582
80. Hoei-Hansen CE, Olesen IA, Jorgensen N, Carlsen E, Holm M, Almstrup K, et al. Current approaches for detection of carcinoma in situ testis. Int J Androl 2007;30:398-404
81. van Casteren NJ, Stoop H, Dohle GR, de Wit R, Oosterhuis JW, Looijenga LH. Noninvasive detection of testicular carcinoma in situ in semen using OCT3/4. Eur Urol 2008;54:153-158
82. Berthelsen JG, Skakkebaek NE. Value of testicular biopsy in diagnosing carcinoma in situ testis. Scand J Urol Nephrol 1981;15:165-168
83. Dieckmann KP, Loy V. False-negative biopsies for the diagnosis of testicular intraepithelial neoplasia (TIN)--an update. Eur Urol 2003;43:516-521 (Pubitemid 36528438)
84. Cappelen T, Fossa SD, Stenwig AE, Aass N. False-negative biopsy for testicular intraepithelial neoplasia and high-risk features for testicular cancer. Acta Oncol 2000;39:105-109
85. Dieckmann KP, Kulejewski M, Pichlmeier U, Loy V. Diagnosis of contralateral testicular intraepithelial neoplasia (TIN) in patients with testicular germ cell cancer: systematic two-site biopsies are more sensitive than a single random biopsy. Eur Urol 2007;51:175-183
86. Souchon R, Gertenbach U, Dieckmann KP, Hahn E, Ruwe M, Stambolis C, et al. Contralateral testicular cancer in spite of TIN-negative double biopsies and interval cisplatin chemotherapy. Strahlenther Onkol 2006;182:289-292
87. Heidenreich A, Moul JW. Contralateral testicular biopsy procedure in patients with unilateral testis cancer: is it indicated? Semin Urol Oncol 2002;20:234-238
88. Dieckmann KP, Heinemann V, Frey U, Pichlmeier U. How harmful is contralateral testicular biopsy?--an analysis of serial imaging studies and a prospective evaluation of surgical complications. Eur Urol 2005;48:662-672
89. Manning M, Junemann KP, Alken P. Decrease in testosterone blood concentrations after testicular sperm extraction for intracytoplasmic sperm injection in azoospermic men. Lancet 1998;352:37
90. Burke AP, Mostofi FK. Intratubular malignant germ cells in testicular biopsies: clinical course and identification by staining for placental alkaline phosphatase. Mod Pathol 1988;1:475-479
91. Huyghe E, Muller A, Mieusset R, Bujan L, Bachaud JM, Chevreau C, et al. Impact of diagnostic delay in testis cancer: results of a large population-based study. Eur Urol 2007;52:1710-1716
92. Bokemeyer C, Schmoll HJ, Schoffski P, Harstrick A, Bading M, Poliwoda H. Bilateral testicular tumours: prevalence and clinical implications. Eur J Cancer 1993;29A:874-876
93. Hentrich M, Weber N, Bergsdorf T, Liedl B, Hartenstein R, Gerl A. Management and outcome of bilateral testicular germ cell tumors: Twenty-five year experience in Munich. Acta Oncol 2005;44:529-536
94. Holzbeierlein JM, Sogani PC, Sheinfeld J. Histology and clinical outcomes in patients with bilateral testicular germ cell tumors: the Memorial Sloan Kettering Cancer Center experience 1950 to 2001. J Urol 2003;169:2122-2125
95. Coogan CL, Foster RS, Simmons GR, Tognoni PG, Roth BJ, Donohue JP. Bilateral testicular tumors: management and outcome in 21 patients. Cancer 1998;83:547-552
96. Fossa SD, Chen J, Schonfeld SJ, McGlynn KA, McMaster ML, Gail MH, et al. Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men. J Natl Cancer Inst 2005;97:1056-1066
97. Petersen PM, Giwercman A, Daugaard G, Rorth M, Petersen JH, Skakkeaek NE, et al. Effect of graded testicular doses of radiotherapy in patients treated for carcinoma-in-situ in the testis. J Clin Oncol 2002;20:1537-1543
98. Patel SR, Richardson RL, Kvols L. Synchronous and metachronous bilateral testicular tumors. Mayo Clinic experience. Cancer 1990;65:1-4
99. von der Maase H, Berthelsen JG, Jacobsen GK, Hald T, Rorth M, Christophersen IS, et al. Carcinoma-in-situ of testis eradicated by chemotherapy. Lancet 1985;1:98
100. Christensen TB, Daugaard G, Geertsen PF, von der Maase H. Effect of chemotherapy on carcinoma in situ of the testis. Ann Oncol 1998;9:657-660
101. Kleinschmidt K, Dieckmann KP, Georgiew A, Loy V, Weissbach L. Chemotherapy is of limited efficacy in the control of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell cancer. Oncology 2009;77:33-39
102. Bottomley D, Fisher C, Hendry WF, Horwich A. Persistent carcinoma in situ of the testis after chemotherapy for advanced testicular germ cell tumours. Br J Urol 1990;66:420-424
103. Dieckmann KP, Loy V. Intratesticular effects of cisplatin-based chemotherapy. Eur Urol 1995;28:25-30
104. Geldart TR, Simmonds PD, Mead GM. Orchidectomy after chemotherapy for patients with metastatic testicular germ cell cancer. BJU Int 2002;90:451-455
105. Snow BW, Rowland RG, Donohue JP, Einhorn LH, Williams SD. Review of delayed orchiectomy in patients with disseminated testis tumors. J Urol 1983;129:522-523
106. Giwercman A, von der Maase H, Berthelsen JG, Rorth M, Bertelsen A, Skakkebaek NE. Localized irradiation of testes with carcinoma in situ: effects on Leydig cell function and eradication of malignant germ cells in 20 patients. J Clin Endocrinol Metab 1991;73:596-603
107. Petersen PM, Giwercman A, Hansen SW, Berthelsen JG, Daugaard G, Rorth M, et al. Impaired testicular function in patients with carcinomain- situ of the testis. J Clin Oncol 1999;17:173-179
108. Giwercman A, von der Maase H, Rorth M, Skakkebaek NE. Semen quality in testicular tumour and CIS in the contralateral testis. Lancet 1993;341:384-385
109. Heidenreich A, Vorreuther R, Neubauer S, Zumbe J, Engelmann UH. Paternity in patients with bilateral testicular germ cell tumors. Eur Urol 1997;31:246-248 (Pubitemid 27101717)
110. Carroll PR, Whitmore WF, Jr., Herr HW, Morse MJ, Sogani PC, Bajorunas D, et al. Endocrine and exocrine profiles of men with testicular tumors before orchiectomy. J Urol 1987;137:420-423
111. Sedlmayer F, Holtl W, Kozak W, Hawliczek R, Gebhart F, Gerber E, et al. Radiotherapy of testicular intraepithelial neoplasia (TIN): a novel treatment regimen for a rare disease. Int J Radiat Oncol Biol Phys 2001;50:909-913
112. Bang AK, Petersen JH, Petersen PM, Andersson AM, Daugaard G, Jorgensen N. Testosterone production is better preserved after 16 than 20 gray irradiation treatment against testicular carcinoma in situ cells. Int J Radiat Oncol Biol Phys 2009;75:672-676
113. Heidenreich A, Weissbach L, Holtl W, Albers P, Kliesch S, Kohrmann KU, et al. Organ sparing surgery for malignant germ cell tumor of the testis. J Urol 2001;166:2161-2165
114. Pamenter B, De Bono JS, Brown IL, Nandini M, Kaye SB, Russell JM, et al. Bilateral testicular cancer: a preventable problem? Experience from a large cancer centre. BJU Int 2003;92:43-46